ArticleWorld journal of urology2026
Predicting SIRS after PCNL using machine learning: the joint impact of sarcopenia and staghorn stones.
Article in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Comment on: "Predicting SIRS after PCNL using machine learning: the joint impact of sarcopenia and staghorn stones".World journal of urology · 2026Article
Corrections and comments
- Commented on by
Authors and funding
6 authors.
Funding
Abstract
purposeTo develop and validate machine learning models for predicting systemic inflammatory response syndrome (SIRS) after percutaneous nephrolithotomy (PCNL), to establish a web-based prediction tool, and to investigate the association between sarcopenia and staghorn stones as well as their potential synergistic effect on postoperative SIRS.
methodsPatients undergoing PCNL between January 2021 and August 2025 at The Third Affiliated Hospital of Sun Yat-sen University were retrospectively analyzed and randomly divided into training and validation sets (7:3). Feature selection was performed using elastic net and Boruta. Six machine learning models were developed and compared, with SHAP used for interpretability. The optimal model was used to build a web-based prediction tool. Associations and interaction effects between sarcopenia and staghorn stones were further assessed.
resultsA total of 755 patients were included, with a SIRS incidence of 17.62%. XGBoost achieved the best performance (validation set: AUC = 0.863, accuracy = 0.863, sensitivity = 0.763, specificity = 0.883, F1 score = 0.652). SHAP analysis identified staghorn stones and sarcopenia as the most important predictors. Sarcopenia was positively associated with staghorn stones. A significant synergistic effect on SIRS was observed, confirmed by both multiplicative interaction (OR = 4.229, 95% CI 1.354-14.432, P = 0.016) and additive interaction (RERI = 25.473, AP = 0.854, S = 8.600).
conclusionThe XGBoost model provides robust prediction of postoperative SIRS after PCNL, and the web-based tool may assist in risk stratification. Sarcopenia and staghorn stones are positively associated, and their coexistence is linked to a higher risk of SIRS with a potential positive interaction, highlighting the need for individualized perioperative management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.